Pharmaceuticals

TrueBrand pairs an HSA anti-counterfeit and tamper-evident physical label with a unique GS1 SGTIN identifier in the Trailio identity layer. A patient or pharmacist scan via QR or NFC verifies the identifier against the authentic batch record, returns dosage and expiry information, and contributes scan intelligence used to detect duplicate scans, unauthorised-region scans, and other counterfeit patterns. Suspect scans trigger immediate anomaly intelligence and escalation to regulatory affairs.

A serialised QR or NFC label is only as trustworthy as the physical layer that secures the package. HSA supplies tamper-evident, anti-counterfeit, holographic, and NFC pharmaceutical labels that make any opening attempt visibly and irreversibly evident. Trailio TrueBrand supplies the digital verification, traceability intelligence, anomaly detection, and consumer scan layer. Together, the two layers create a defence that counterfeiters cannot easily defeat by replicating only one side.

Every internal pharmaceutical custody transfer is recorded as a discrete, time-stamped, operator-attributed event in AssetShield - from pallet sealing at the manufacturer, through warehouse handoff, regional hub scan, distributor receipt, hospital or pharmacy verification. HSA pallet covers, security tapes, and seals provide the tamper-evident physical layer at every handoff. Missing or out-of-sequence scans trigger anomaly detection, and the full chain is retained as an evidence pack for reconciliation and regulatory review.

TrueBrand supports DSCSA-compliant serialisation by generating GS1-standard SGTIN identifiers and maintaining EPCIS event records for each product transfer. EU FMD unit-level serialisation, authentication at point of dispense, and decommissioning workflows are supported, with integration into national MAH and verification systems. Pharmacist verification scans are captured and recorded against the product identity for audit and regulatory submission.

At each consumer verification scan and each custody transfer, the product identifier is checked against the Trailio TrueBrand identity record. Identifiers that do not resolve to a genuine manufacture record, have been used more than once, or appear outside the expected distribution pathway trigger immediate alerts. Anomaly intelligence aggregates patterns - duplicate scans, unauthorised-region scans, suspicious scan velocity - and surfaces them to pharmacovigilance and regulatory affairs teams within seconds.

HSA supplies tamper-evident pharmaceutical labels for primary and secondary packaging, holographic and micro-text anti-counterfeit labels, NFC-enabled serialised labels for high-value medicines and supplements, pharmaceutical security seals for shipment closures, security tapes for cartons and pallet wraps, and pallet covers for shipment-level tamper evidence. All HSA pharmaceutical products are serialised and integrate directly with TrueBrand for consumer verification and AssetShield for internal shipment custody.

Every patient and pharmacist scan is captured against the product identity, creating a verifiable trust touchpoint at the moment of dispense. Anomaly intelligence and exception records feed structured evidence packs for pharmacovigilance review, regulatory inspection, and Marketing Authorisation Holder reporting - replacing reconstructed narratives with time-stamped, attributable operational records.